Literature DB >> 32442245

Muscle Mass Assessed by the D3-Creatine Dilution Method and Incident Self-reported Disability and Mortality in a Prospective Observational Study of Community-Dwelling Older Men.

Peggy M Cawthon1,2, Terri Blackwell1, Steven R Cummings1,2, Eric S Orwoll3, Kate A Duchowny2, Deborah M Kado4,5, Katie L Stone1, Kristine E Ensrud6,7, Jane A Cauley8, William J Evans9,10.   

Abstract

BACKGROUND: Whether low muscle mass is a risk factor for disability and mortality is unclear. Associations between approximations of muscle mass (including lean mass from dual-energy x-ray absorptiometry [DXA]), and these outcomes are inconsistent.
METHODS: Muscle mass measured by deuterated creatine (D3Cr) dilution and appendicular lean mass (ALM, by DXA) were assessed at the Year 14 Visit (2014-2016) of the prospective Osteoporotic Fractures in Men study (N = 1,425, age 77-101 years). Disability in activities of daily living (ADLs), instrumental ADLs, and mobility tasks was self-reported at the Year 14 visit and 2.2 years later; deaths were centrally adjudicated over 3.3 years. Relative risks and 95% confidence intervals (CI) were estimated per standard deviation decrement with negative binomial, logistic regression, or proportional hazards models.
RESULTS: In age- and clinical center-adjusted models, the relative risks per decrement in D3Cr muscle mass/wgt was 1.9 (95% CI: 1.2, 3.1) for incident self-reported ADL disability; 1.5 (95% CI: 1.3, 1.9) for instrumental ADL disability; and 1.8 (95% CI: 1.5, 2.2) for mobility disability. In age-, clinical center-, and weight-adjusted models, the relative risks per decrement in D3Cr muscle mass was 1.8 (95% CI: 1.5, 2.2) for all-cause mortality. In contrast, lower DXA ALM was not associated with any outcome. Associations of D3Cr muscle mass with these outcomes were slightly attenuated after adjustment for confounding factors and the potentially mediating effects of strength and physical performance.
CONCLUSIONS: Low muscle mass as measured by D3Cr dilution is a novel risk factor for clinically meaningful outcomes in older men.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Death; Disability; Muscle mass

Year:  2021        PMID: 32442245      PMCID: PMC7756711          DOI: 10.1093/gerona/glaa111

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  34 in total

1.  Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans.

Authors:  Richard V Clark; Ann C Walker; Robin L O'Connor-Semmes; Michael S Leonard; Ram R Miller; Stephen A Stimpson; Scott M Turner; Eric Ravussin; William T Cefalu; Marc K Hellerstein; William J Evans
Journal:  J Appl Physiol (1985)       Date:  2014-04-24

2.  Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child-clinical and pediatric psychology literatures.

Authors:  G N Holmbeck
Journal:  J Consult Clin Psychol       Date:  1997-08

3.  Overview of recruitment for the osteoporotic fractures in men study (MrOS).

Authors:  Janet Babich Blank; Peggy Mannen Cawthon; Mary Lou Carrion-Petersen; Loretta Harper; J Phillip Johnson; Eileen Mitson; Romelia Ramírez Delay
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

4.  Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code.

Authors:  Li Cao; John E Morley
Journal:  J Am Med Dir Assoc       Date:  2016-08-01       Impact factor: 4.669

5.  International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; H Arai; S B Kritchevsky; J Guralnik; J M Bauer; M Pahor; B C Clark; M Cesari; J Ruiz; C C Sieber; M Aubertin-Leheudre; D L Waters; R Visvanathan; F Landi; D T Villareal; R Fielding; C W Won; O Theou; F C Martin; B Dong; J Woo; L Flicker; L Ferrucci; R A Merchant; L Cao; T Cederholm; S M L Ribeiro; L Rodríguez-Mañas; S D Anker; J Lundy; L M Gutiérrez Robledo; I Bautmans; I Aprahamian; J M G A Schols; M Izquierdo; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

6.  Psoas and Paraspinous Muscle Measurements on Computed Tomography Predict Mortality in European Americans with Type 2 Diabetes Mellitus.

Authors:  B M Tucker; F C Hsu; T C Register; J Xu; S C Smith; M Murea; D W Bowden; B I Freedman; L Lenchik
Journal:  J Frailty Aging       Date:  2019

7.  Sarcopenia: alternative definitions and associations with lower extremity function.

Authors:  Anne B Newman; Varant Kupelian; Marjolein Visser; Eleanor Simonsick; Bret Goodpaster; Michael Nevitt; Stephen B Kritchevsky; Frances A Tylavsky; Susan M Rubin; Tamara B Harris
Journal:  J Am Geriatr Soc       Date:  2003-11       Impact factor: 5.562

Review 8.  Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons.

Authors:  Laura A Schaap; Annemarie Koster; Marjolein Visser
Journal:  Epidemiol Rev       Date:  2012-12-04       Impact factor: 6.222

9.  Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials.

Authors:  Stephen B Kritchevsky; Kristen M Beavers; Michael E Miller; M Kyla Shea; Denise K Houston; Dalane W Kitzman; Barbara J Nicklas
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

10.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

View more
  16 in total

1.  Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.

Authors:  Lorenzo M Donini; Luca Busetto; Stephan C Bischoff; Tommy Cederholm; Maria D Ballesteros-Pomar; John A Batsis; Juergen M Bauer; Yves Boirie; Alfonso J Cruz-Jentoft; Dror Dicker; Stefano Frara; Gema Frühbeck; Laurence Genton; Yftach Gepner; Andrea Giustina; Maria Cristina Gonzalez; Ho-Seong Han; Steven B Heymsfield; Takashi Higashiguchi; Alessandro Laviano; Andrea Lenzi; Ibolya Nyulasi; Edda Parrinello; Eleonora Poggiogalle; Carla M Prado; Javier Salvador; Yves Rolland; Ferruccio Santini; Mireille J Serlie; Hanping Shi; Cornel C Sieber; Mario Siervo; Roberto Vettor; Dennis T Villareal; Dorothee Volkert; Jianchun Yu; Mauro Zamboni; Rocco Barazzoni
Journal:  Obes Facts       Date:  2022-02-23       Impact factor: 4.807

2.  Association Between Muscle Mass Determined by D3 -Creatine Dilution and Incident Fractures in a Prospective Cohort Study of Older Men.

Authors:  Peggy M Cawthon; Katherine E Peters; Steven R Cummings; Eric S Orwoll; Andrew R Hoffman; Kristine E Ensrud; Jane A Cauley; William J Evans
Journal:  J Bone Miner Res       Date:  2022-03-06       Impact factor: 6.390

3.  Appendicular Lean Mass, Grip Strength, and the Development of Hospital-Associated Activities of Daily Living Disability Among Older Adults in the Health ABC Study.

Authors:  James S Andrews; Laura S Gold; May J Reed; Jose M Garcia; Robyn L McClelland; Annette L Fitzpatrick; Catherine L Hough; Peggy M Cawthon; Ken E Covinsky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-07-05       Impact factor: 6.591

4.  Body Composition by Computed Tomography vs Dual-Energy X-ray Absorptiometry: Long-Term Prediction of All-Cause Mortality in the Health ABC Cohort.

Authors:  Samaneh Farsijani; Lingshu Xue; Robert M Boudreau; Adam J Santanasto; Stephen B Kritchevsky; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-11-15       Impact factor: 6.053

Review 5.  Exercise-Based Interventions to Counteract Skeletal Muscle Mass Loss in People with Cancer: Can We Overcome the Odds?

Authors:  Kelcey A Bland; Imre W K Kouw; Luc J C van Loon; Eva M Zopf; Ciaran M Fairman
Journal:  Sports Med       Date:  2022-02-04       Impact factor: 11.136

6.  Factor analysis to determine relative contributions of strength, physical performance, body composition and muscle mass to disability and mobility disability outcomes in older men.

Authors:  Jesse Zanker; Terri Blackwell; Sheena Patel; Kate Duchowny; Sharon Brennan-Olsen; Steven R Cummings; William J Evans; Eric S Orwoll; David Scott; Sara Vogrin; Gustavo Duque; Peggy M Cawthon
Journal:  Exp Gerontol       Date:  2022-01-29       Impact factor: 4.032

7.  CT Muscle Density, D3Cr Muscle Mass, and Body Fat Associations With Physical Performance, Mobility Outcomes, and Mortality Risk in Older Men.

Authors:  Eric S Orwoll; Terri Blackwell; Steven R Cummings; Jane A Cauley; Nancy E Lane; Andrew R Hoffman; Andrew J Burghardt; William J Evans; Peggy M Cawthon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

8.  The Association of Muscle Mass Measured by D3-Creatine Dilution Method With Dual-Energy X-Ray Absorptiometry and Physical Function in Postmenopausal Women.

Authors:  Kexin Zhu; Jean Wactawski-Wende; Heather M Ochs-Balcom; Michael J LaMonte; Kathleen M Hovey; William Evans; Mahalakshmi Shankaran; Bruce R Troen; Hailey R Banack
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-08-13       Impact factor: 6.053

Review 9.  Protein Intake and Frailty: A Matter of Quantity, Quality, and Timing.

Authors:  Hélio J Coelho-Junior; Emanuele Marzetti; Anna Picca; Matteo Cesari; Marco C Uchida; Riccardo Calvani
Journal:  Nutrients       Date:  2020-09-23       Impact factor: 5.717

Review 10.  Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?

Authors:  Anna Picca; Riccardo Calvani; Matteo Cesari; Francesco Landi; Roberto Bernabei; Hélio José Coelho-Júnior; Emanuele Marzetti
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.